Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,575 | 3,034 | 3,616 | 1,272 | 3,217 |
| Marketable Securities | 1,057 | 1,717 | 2,379 | 2,859 | 1,515 |
| TOTAL | $6,656 | $4,839 | $6,050 | $4,169 | $4,742 |
| Non-Current Assets | |||||
| Intangibles | 102 | 142 | 182 | 222 | 262 |
| Other Non-Current Assets | 1,308 | 1,692 | 1,705 | 1,377 | 0 |
| TOTAL | $1,410 | $1,834 | $1,887 | $1,599 | $262 |
| Total Assets | $8,066 | $6,673 | $7,937 | $5,768 | $5,004 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 402 | 676 | 805 | 992 | 1,530 |
| TOTAL | $402 | $676 | $805 | $992 | $1,672 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $402 | $676 | $805 | $992 | $1,672 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,821 | 20,744 | 16,849 | 16,693 | 12,847 |
| Common Shares | 21 | 18 | 500 | 14 | 13 |
| Retained earnings | -12,897 | -11,499 | -10,077 | -8,815 | -7,835 |
| TOTAL | $7,664 | $5,997 | $7,132 | $4,776 | $3,332 |
| Total Liabilities And Equity | $8,066 | $6,673 | $7,937 | $5,768 | $5,004 |